Vertex Pharmaceuticals (VRTX) EPS (Basic) Growth (3y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 139.68% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 25.99% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 41.58% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.28% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 58.35% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -2.92% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 45.92% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.28% |
| Dec 31, 2025 | 13.71% |
| Sep 30, 2025 | 5.31% |
| Jun 30, 2025 | 8.24% |
| Mar 31, 2025 | -5.54% |
| Dec 31, 2024 | 5.46% |
| Sep 30, 2024 | 7.06% |
| Jun 30, 2024 | -281.53% |
| Mar 31, 2024 | 19.13% |
| Dec 31, 2023 | 17.46% |
| Sep 30, 2023 | 16.14% |
| Jun 30, 2023 | 3.31% |
| Mar 31, 2023 | 5.45% |
| Dec 31, 2022 | 12.17% |
| Sep 30, 2022 | 154.58% |
| Jun 30, 2022 | 44.99% |
| Mar 31, 2022 | 41.74% |
| Dec 31, 2021 | -20.89% |
| Sep 30, 2021 | 86.34% |
| Jun 30, 2021 | -31.81% |
| Mar 31, 2021 | 44.80% |
| Dec 31, 2020 | 79.67% |
| Sep 30, 2020 | 102.01% |
| Jun 30, 2020 | 258.30% |
| Mar 31, 2020 | 31.94% |
| Dec 31, 2019 | 159.05% |
| Sep 30, 2019 | 50.00% |
| Jun 30, 2019 | 81.71% |
| Mar 31, 2019 | 101.46% |
| Dec 31, 2018 | 178.55% |
| Sep 30, 2018 | 49.00% |
| Jun 30, 2018 | 45.04% |
| Mar 31, 2018 | 44.22% |
| Dec 31, 2017 | 36.45% |
| Sep 30, 2017 | 17.11% |
| Jun 30, 2017 | 28.12% |
| Mar 31, 2017 | 44.39% |
| Dec 31, 2016 | -11.88% |
| Sep 30, 2016 | 32.92% |
| Jun 30, 2016 | 0.00% |
| Mar 31, 2016 | 50.83% |
| Dec 31, 2015 | 3.96% |
| Sep 30, 2015 | -13.04% |
| Jun 30, 2015 | -36.01% |
| Mar 31, 2015 | -57.22% |
| Dec 31, 2014 | -43.80% |
| Sep 30, 2014 | -38.89% |
| Mar 31, 2014 | -4.75% |
| Dec 31, 2013 | 30.28% |
| Sep 30, 2013 | 20.12% |
| Jun 30, 2013 | 36.17% |
| Mar 31, 2013 | -19.88% |
| Dec 31, 2012 | 25.89% |
| Sep 30, 2012 | 31.50% |
| Jun 30, 2012 | 32.09% |
| Mar 31, 2012 | 34.31% |